Cytotoxicity evaluation of curcumin-loaded affibody-decorated liposomes against breast cancerous cell lines. (3rd April 2021)

• Record Type: Journal Article
• Authors: Moballegh-Nasery, Mahshid; Mandegary, Ali; Eslaminejad, Touba; Zeinali, Majid; Pardakhti, Abbas; Behnam, Behzad; Mohammadi, Mohadeseh
• Is Part Of: Journal of liposome research. Volume 31:Number 2(2021)
• Page Start: 189
• Page End: 194
• Publication Date: 2021-04-03
• Subjects: Curcumin -- HER2 -- breast cancer -- affisome -- targeted therapy; Liposomes -- Periodicals; Liposomes -- Periodicals; 575.57
• DOI: 10.1080/08982104.2020.1755981
• Languages: English
• ISSNs: 0898-2104

Abstract

Abstract: Curcumin is known as an effective anticancer herbal medicine but unfortunately, its bioavailability is poor which necessitate efforts for developing more efficient and specific delivery systems. Human epidermal growth factor receptor 2 (HER 2) due to its overexpression in various types of cancers, is demonstrated to be a good candidate as a target for anticancer therapy. In this study, cytotoxicity of curcumin encapsulated in ZHER2:342 Affibody-decorated liposome was investigated against SKBR3 and MCF-7 cancerous cell lines. Curcumin-containing liposomes were prepared from soybeans lecetin and cholesterol by thin-film hydration method. Affibody ZHER2:342 molecules via C-terminal cysteine residue were conjugated covalently to the prepared liposomes. Particle size analysis was performed using atomic force microscopy (AFM) and dynamic light scattering (DLS). Curcumin loading was measured using UV-Vis spectrophotometry and cytotoxic activity of curcumin formulations against cancerous cell lines was investigated by MTT assay. Induction of apoptosis was investigated using flow cytometry through Annexin V staining. Particle analysis showed the formation of spherical liposomes with a mean diameter of about 150 nm. Cytotoxic activity of curcumin was improved by its encapsulation in both liposomes and affibody-decorated liposomes. The Annexin V staining indicated the induction of apoptosis by affibody-decorated liposomes in both MCF-7 and SKBR3 cells. Decoration of curcumin-loaded liposomes with affibody ZHER2:342 may improve curcumin apoptotic function independently of HER2 expression level.